United Therapeutics | UTHR - Ativo Circulante





Ativo Circulante Alterar Data
Amarin USD 612.88M 10.12M 2026-09
Ardelyx USD 441.39M 538K 2026-09
Baxter International USD 6.83B 163M 2026-09
Bayer EUR 39.6B 5.96B 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Insmed USD 1.71B 72.59M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
J&J USD 56.35B 3.42B 2026-09
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Moderna USD 7.34B 1.53B 2026-09
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 45.01B 3.65B 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Teva Pharmaceutical Industries USD 14.6B 842M 2026-09
United Therapeutics USD 2.88B 603.5M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09